Waters™ Corporation has announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters’ ability to build a high-growth business in bioanalytical characterization for new modalities...

Waters Corp introduces its newest MaxPeak Premier Oligonucleotide Columns – now with ethylene bridged hybrid (BEH) particle technology in 300Å wide pore versions – providing industry-leading chromatographic resolution for long-mer oligonucleotide separations to support applications for nucleic acid therapeutics and cell and gene therapies. The new columns have all the benefits customers can expect from Waters’ MaxPeak Premier high performance surface chemistry and BEH particle technology...

Waters Corporation has unveiled its next generation Xevo TQ Absolute IVD mass spectrometer, expanding its family of MassTrak IVD LC-MS/MS Systems for clinical diagnostic applications. The powerful analytical performance of the Xevo TQ Absolute IVD mass spectrometer is up to five times more sensitive for quantifying clinical analytes than similar commercial instruments on the market...

Waters Corporation has introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use. When combined with Waters’ compliance-ready Empower Chromatography Software and eConnect™ HPLC Columns, the Alliance iS High Performance Liquid Chromatography (HPLC) System streamlines the task of making accurate and precise measurements by detecting and eliminating common errors by up to 40%...

Waters Corp announces RapiZyme™ Trypsin, a chemically optimized, recombinant trypsin. This trypsin provides gold-standard performance while cutting lengthy digestion times from over three hours to just 30 minutes. RapiZyme trypsin’s industry-leading autolysis resistance enables use at higher enzyme-to-protein ratios, allowing for rapid and uncompromising 30-minute digestions without resorting to high temperature...

Waters Corporation (NYSE:WAT) has announced it has entered into an agreement to acquire Wyatt Technology, a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories, and services, for $1.36 billion in cash, subject to certain adjustments. The transaction is expected to close in the second quarter of 2023, subject to regulatory approvals and other customary closing conditions...

Waters Corp announces a new test protocol for its Waters LC/GC Certified Vials along with a new addition to its line of Waters TruView pH Control LC/MS Certified Vials. The Waters LC/GC Certified Vials undergo a new and highly-sensitive UPLC-UV Certification test at 195nm at a contamination level of <100 ppb to ensure that not just the sample vial – but its cap and septum too – are all free of contamination...

Waters Corporation has announced waters_connect™ System Monitoring, a new Software-as-a-Service (SaaS) application that enables laboratory managers and analysts to monitor the real-time status of any chromatography instruments, regardless of the manufacturer, running on Waters™ Empower™ Software. The waters_connect System Monitoring application was developed especially for high-volume quality assurance/quality control (QA/QC) laboratories...

Waters Corporation introduced Extraction+ Connected Device, a new software-controlled product for the Waters™ Andrew+™ Pipetting Robot that automates the preparation of biological, food, forensics and environmental samples by solid phase extraction (SPE). The Extraction+ Connected Device eliminates the need to manually pipette and extract samples with a hands-free, automated approach to SPE. It can save scientists up to four hours of bench time for each sample set and reduce the risk of user-to-user variability...

Waters Corporation announce a combined investment of up to €6 million with support from IDA Ireland to expand its operations in Drinagh, Wexford to fund research and development (R&D) of new clinical diagnostics products. The operational expansion at the Wexford facility will create new scientific jobs through 2024. Waters’ Wexford facility is the company’s primary site for manufacturing and delivery of its portfolio of in-vitro diagnostic (IVD) systems, reagent kits, and software...

Waters Corporation announced it is providing both technology and expertise to help advance plant-based protein science in collaboration with researchers of the Plant Protein Innovation Center (PPIC) at the University of Minnesota. Waters scientists will work with PPIC researchers to develop a workflow for measuring the amino acid content of plant-based proteins using a Waters ACQUITY™ Premier UPLC System....

Waters Corporation has unveiled new instruments, software and product enhancements to drive drug discovery and development at the American Society for Mass Spectrometry (ASMS) 2022 Annual Conference. The products include the new Xevo™ G3 quadrupole time-of-flight (QTof) mass spectrometer, CONFIRM Sequence - a new oligonucleotide sequencing confirmation app...

Waters Corporation has introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its class. Waters’ newest high-performance mass spectrometer is up to 15X more sensitive for quantifying negatively ionizing compounds than its predecessorii and is 45% smaller and uses up to 50% less electricity and gas supply than other high-performance tandem quadrupole mass spectrometers available on the market..

Waters Corporation has introduced new software and analytical columns to aid biomolecule drug discovery and development. The new Waters™ Intact Mass app on waters_connect™ allows scientists using the BioAccord™ LC-MS System to confirm the mass of biomolecules and impurities made by synthetic or recombinant processes nearly twice as fast as other commercially available options...

Waters Corporation announce it has acquired the technology assets and intellectual property rights of Megadalton Solutions, Inc., an early-stage developer of Charge Detection Mass Spectrometry (CDMS) technology and services. Financial details of the transaction are not being disclosed. Founded in 2018 by professors Martin Jarrold and David Clemmer at Indiana University, Megadalton Solutions has developed CDMS instrumentation that makes it possible to analyze extremely large proteins and protein complexes...

Sartorius and Waters will partner to implement the BioAccord™ LC-MS System from Waters as a new bioprocess analyzer with data connectivity to Sartorius’ Ambr® multi-parallel bioreactor systems to deliver mass spectral information on drug substances, related analytes and cell culture media. This combination will greatly accelerate and improve the accuracy and speed of tasks from clone selection to bioprocess optimization...

Waters Corporation has introduced the Waters™ BioAccord™ System with ACQUITY™ Premier, a combination of the Waters BioAccord System and the breakthrough ACQUITY Premier UPLC™ with MaxPeak™ High Performance Surface (HPS) technology. The integrated high-resolution LC-MS system simplifies multi-attribute monitoring of biotherapeutics by improving analyte recovery and assay-to-assay reproducibility so that regulated laboratories can get needed medicines to patients faster....

Waters Corporation has introduced TRIOS AutoPilot software from its TA Instruments Division for its thermal analyzer product line. The software helps laboratory staff using TA’s thermal analyzers create routine and streamlined standard operating procedures (SOPs) up to 25% faster, and avoid transcription errors that can inhibit productivity and can lead to inconsistent thermal analysis measurements that are used to assess materials performance as well as batch-to-batch product quality....

Waters and The Bioprocessing Technology Institute (BTI) are engaging in data analytics research meant to eliminate a major bottleneck in the characterization of biopharmaceuticals, namely the identification and quantitation of complex biomolecules such as released N- and O- glycans and metabolites that influence therapeutic function. Isomerism of both glycans and metabolites is particularly troublesome and can be tackled using Waters’ advanced instruments....

Waters Corporation has introduced the Waters™ Arc™ Premier System, the first liquid chromatography system optimized for chromatographic separations on 2.5 – 3.5 micron columns to also feature Waters’ novel MaxPeak™ High Performance Surface (HPS) technology. The new system complements Waters’ best-selling MaxPeak Premier Columns to virtually eliminate the surface interactions that occur between sample analytes and instrument and column hardware, saving laboratories time wasted on costly...

Waters Corporation introduces the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with both enhanced DESI and new MALDI imaging sources. Together, these technologies enable scientists to explore molecular structure and function through the precise identification and localization of individual molecules in samples, with a unique combination of speed, resolution, and mass accuracy....

Waters Corporation and Genovis AB are formally collaborating to develop and market complete routine biopharmaceutical characterization workflows based on the Waters™ BioAccord™ LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes™. The goal of the collaboration is to develop automated workflows for the rapid and consistent characterization of critical quality attributes (CQAs) of monoclonal antibodies (mAbs) and other protein-based drugs in bioprocess development...

Waters Corporation has released the ACQUITY RDa™ Detector featuring SmartMS™, the company’s newest time-of-flight (TOF) mass spectrometer (MS) for small molecule analysis for pharmaceutical, academic, food, and forensics applications. The accurate-mass ACQUITY™ RDa Detector can be quickly deployed and operated to enable faster and more informed decision-making across a broad set of applications....

Waters Corporation introduces the Waters™ ACQUITY™ PREMIER Solution, the next generation in liquid chromatographs featuring Waters’ breakthrough MaxPeak™ High Performance Surface (HPS) technology. The solution leverages HPS to vastly improve analytical data quality and eliminate the need for time-consuming and costly passivation. ACQUITY PREMIER is a universal liquid chromatograph (LC) solution that combines the ACQUITY PREMIER System with ACQUITY PREMIER Columns with MaxPeak HPS technology....

Waters Corporation introduces the Otto^TM SPEcialist Positive Pressure Manifold designed to improve the reliability and reproducibility of solid phase extraction (SPE). Equipped with easy-to-use, 21 CFR Part 11 compliant software and programmable pressure profiles, the Otto SPEcialist system provides confidence in SPE results by eliminating common workflow errors, reducing user variability, and documenting each method step to remove uncertainty and prevent duplicative efforts....

Waters Corporation (NYSE:WAT) today announced that its Xevo TQ-XS atmospheric pressure gas chromatography (APGC) mass spectrometry (MS) platform is an accepted alternative for the identification and quantification of dioxins and furans in environmental samples. Dioxins are a byproduct of human industrial activity and their effects on human health are well documented....

Waters Corporation has introduced the Waters™ Arc™ HPLC System, a new high-performance liquid chromatograph (HPLC) for routine testing in the pharmaceutical, food, academic and materials markets. A key target application is quality control laboratories performing batch release tests on small molecule pharmaceuticals. Waters also announced the availability of Waters™ Empower™ BC LAC/E™ with SecureSync, its newly enhanced data back-up and recovery solution purpose-built for organizations with distributed laboratory environments....

Waters Corporation has announced a new fragmentation technique and an imaging option for its high-resolution mass spectrometers giving research scientists working across a broad range of end markets including biomedical, biopharmaceutical and food research, greater experimental freedom to explore the intricacies of peptides, proteins, and protein complexes....

Waters Corporation has announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves the use of automation technology, enabling more scientists to realize the advantages of repeatability and performance for both routine and complex laboratory workflows....

Aston University and Waters Corporation has announced the completed installation of the world’s first Waters™ SELECT SERIES™ Cyclic™ IMS (ion mobility spectrometry) mass spectrometer within the University’s School of Health and Life Sciences, where the instrument will support research into the biology of human diseases, the discovery of new therapeutics and advances in biotechnology....

Designed for Quantitative Analysis, Waters Full Portfolio of TQ MS Systems Make High Performance and Routine Analysis Accessible, Robust, Reliable. The highly-acclaimed Xevo TQ-S micro features new performance enhancements that bring the quantitation of highly polar, ionic compounds in food to a higher level. The Xevo TQ-S cronos is a new, tandem quadrupole mass spectrometer....

Waters Corporation has announced the availability of a range of new TA Instruments™ innovations headlined by the Discovery™ Thermomechanical Analyzer (TMA) 450, a Rheo-Raman™ capability for the Discovery Hybrid Rheometer, and a High Sensitivity Pressure Cell for the ARES-G2 Rheometer at the 2019 Pittcon Conference and Expo. “High performance materials require high performance measurements. Our new products reflect our unwavering commitment to innovate...

Waters Corporation has introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists. The BioAccord System promises to move routine monitoring out of centralized MS labs and into the hands of more scientists by enabling more effective analysis of biotherapeutic protein attributes across development and within quality control organizations.

Waters Corporation has introduced a new amino acid analysis kit that reduces the time required to quantify amino acids, a critical application for research scientists investigating the physiological underpinnings of disease. The new Kairos™ Amino Acid Analysis Kit consisting of reagents, standards, an analytical column and associated methodology is capable of cutting analytical run times that can range up to two hours to run times of 10 minutes or less....

Waters Corporation introduced the RenataDX™ Screening System, a flow-injection tandem mass spectrometry (FIA-MS/MS) system for rapid high-throughput analysis of extracted dried blood spots and other human biological matrices. “Waters has long been a trusted specialty measurement partner for mass spectrometry in the clinical laboratory. Continuing that history of purposeful innovation, the RenataDX Screening System is designed to ensure ease of use in clinical situations where system performance is critical...

By integrating UNIFI™ acquired data from the Vion IMS QTof™ or Xevo™G2 XS mass spectrometers with Molecular Discovery’s Mass-MetaSite and WebMetabase processing software, drug metabolism and pharmacokinetics (DMPK) scientists now have new analysis capabilities across a variety of molecules. Waters UNIFI Scientific Information System is the first software platform to merge LC and high performance MS data (both quadrupole and time-of-flight) into a single solution....

Waters is giving scientists attending ASMS 2018 a first look at new mass spectrometry technologies developed to serve the multi-faceted analytical requirements of food testing, university and biomedical research laboratories. The new products include a gas chromatography-mass spectrometry/mass spectrometry (GC-MS/MS) system for food safety analyses and a direct-analysis mass spectrometry system for rapid molecular fingerprinting of food commodities, ingredients and processed products....

Waters Corporation has introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS. In addition to getting performance-driven columns, users of BioResolve brand columns will receive application-focused standards, templated methods, and an enhanced level of applications support....

Waters Corporation (NYSE:WAT) has introduced the Waters® ACQUITY™ Arc™ Bio System, a versatile, iron-free, bio-inert, quaternary liquid chromatograph specifically engineered to enable the efficient transfer and improvement of bioseparation analytical methods regardless of the LC platform on which the original method was developed. Since its 2015 launch, the original ACQUITY Arc System has become a workhorse of pharmaceutical development and QC laboratories throughout the world....

New Sample Preparation Workflow Produces Exceptionally Clean Samples for Robust and Accurate LC and LC-MS Quantification

Firms to Co-Market New Semi-Automated Sample Preparation Approach for Protein Therapeutics Glycosylation Profiling

Waters Corporation (NYSE:WAT) and Andrew Alliance have signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS....

Waters Collaborates With IonSense on Direct Analysis for Mass Detection Waters and IonSense Exploring the Possibilities Enabled by Coupling the IonSense DART Source to the Waters ACQUITY QDa Mass Detector

Waters Corporation (NYSE:WAT) have announced a collaborative engagement with IonSense (Saugus, Mass.) to interface the compact Waters® ACQUITY® QDa® Mass Detector with the IonSense® DART® ionization source....

Single LC Platform Leads the Way to Enhanced Productivity by Replicating, Improving or Adjusting Established LC Methods

Waters Corporation (NYSE:WAT) today introduced the Waters® ACQUITY® Arc™ System, a quaternary liquid chromatograph that gives analytical laboratories running established LC methods a clear choice for replicating or improving their separations performance. With this new addition to the ACQUITY product line, the new ACQUITY Arc System is specifically engineered to respond to the needs of analytical scientists for a single LC platform that...

Ion Mobility Spectrometry and REIMS Direct-from-sample Ionization Deliver Greater Clarity, Confidence and Speed to Routine LC-MS and MS Analyses

Waters Corporation (NYSE:WAT) at the 63^rd conference of the Society of Mass Spectrometry announced the introduction of new technologies and innovations for mass spectrometry, intended to give laboratories greater levels of detail for every analysis. The introductions include the new Waters^® Vion IMS QTof Mass Spectrometer, a new bench-top tandem mass spectrometer featuring ion mobility and REIMS Research System with iKnife Sampling...

SDL (LSE: SDL) today announced that Waters Corporation, an innovator in the field of analytical chemistry, has selected SDL Knowledge Center to streamline its content creation and management process, drive content reuse and promote standardization of its documentation to deliver a better customer experience.

For more than 50 years, Waters Corporation has developed analytical technologies - hardware, software and chemistries - to advance healthcare delivery, environmental management, food safety, water quality, consumer product development, and high value-added chemicals. Waters’ technical communications department – a subsidiary of the marketing department – produces numerous installation guides, user manuals, system guides and...

Waters Corporation has announced that its ionKey/MS System™ was ranked among thetop analytical instrument innovations of 2014 by The Analytical Scientist magazine.

Introduced at Pittcon 2014, ionKey/MS represents a new approach for achieving exceptional sensitivity, robustness and ease-of-use out of mass spectrometry for applications as far-ranging as bioanalyses, pharmacokinetic studies, and biomarker validation to food safety and environmental analyses. Intended for use with the Waters ACQUITY^® UPLC^® M-Class System and Waters mass spectrometers including the Xevo^® TQ-S Mass Spectrometer and SYNAPT^® G2-Si Mass Spectrometer, the Waters^® ionKey/MS System physically integrates a UPLC separation into the mass spectrometer....

The Right Honourable George Osborne MP joins Waters CEO Doug Berthiaume to mark the official opening of the Waters Mass Spectrometry Headquarters in Wilmslow

Waters Corporation (NYSE: WAT) celebrated the official opening of its new, custom-built mass spectrometry headquarters in Wilmslow, UK, confirming the company's commitment to innovation and the expanded usage of mass spectrometry. The facility has been designed and equipped to accelerate innovation in the field of mass spectrometry – a sophisticated analytical laboratory technology that is entrenched in our everyday lives....

Waters Introduces Xevo G2-XS QTof and Xevo TQ-S micro Mass Spectrometers, Taking Benchtop Quantitative and Qualitative MS Applications to New Levels

Company also Expands ionKey/MS System to SYNAPT and Xevo Time-of-Flight Mass Spectrometers with New UPLC-Grade iKey Chemistries.
Waters Corporation (NYSE:WAT) today introduced two new Xevo® mass spectrometers and expanded the ionKey/MS System at the 62nd conference of the American Society of Mass Spectrometry (ASMS). The Waters® Xevo G2-XS mass spectrometer, a new high performance benchtop quadrupole time-of-flight (QTofTM) mass spectrometer, and the Xevo TQ-S micro, a new and compact benchtop tandem quadrupole mass spectrometer, take...

Waters Corporation (NYSE:WAT) today expanded its family of CORTECS® Columns with the introduction of a new line of 2.7 micron silica-based, solid-core particle columns that set a new standard for HPLC column performance.

TA Instruments today announced the acquisition of Expert System Solutions, ESS (Modena, Italy).

ESS is a privately held company that designs and manufactures innovative non-contact optical thermal analysis instrumentation. Key products from ESS include optical dilatometers in horizontal and vertical orientation with simultaneous DTA measurements, heating microscopes, and an optical fleximeter. ESS systems operate over a wide temperature range, and are a powerful new tool for characterizing metals, ceramics, glasses and other organic and inorganic materials...

ACQUITY QDa and ionkey/MS Drive LC/MS Convergence with Mass Detection for Chromatographers and Separations for Spectrometrists Respectively

Waters^® Corporation (NYSE: WAT) today celebrated the ten-year anniversary of the ACQUITY^® UltraPerformance LC^® (UPLC^®) System, a technology that created a new industry standard for chromatographic performance.   Looking forward, Waterstoday also introduced the new ionKey/MS™ System, a new approach for getting exceptional sensitivity, robustness and ease-of-use out of mass spectrometry and featured the ACQUITY QDa™, the first mass detector to bring high-quality, mass spectral data to chromatographic separations, in its Pittcon debut...

2014 Honor Marks Fourth Time in Last Ten Years Waters' has been recognized by Pittcon Media Corps

Waters Corporation is proud to announce that the Pittcon Editors' Silver award for the most innovative product introduced at the 2014 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy goes to the Waters® ACQUITY  QDa™ Detector. "On behalf Waters employees worldwide, we are honored that the Pittcon Editors have recognized the new ACQUITY QDa Detector at this year's Pittsburgh Conference," said Art Caputo, President of the Waters Division for Waters Corporation....

Waters Introduces UPLC System for nano- to Microscale Separations – the ACQUITY UPLC M-Class System 

New UPLC System and Columns Drive Separations Efficiency and the Sensitivity of LC-MS Analyses to New Levels. Waters Corporation (WAT:NYSE) today introduced the new Waters® ACQUITY UPLC® M-Class System, an industry-first nano- to microscale UltraPerformance LC® (UPLC®) system rated for 15,000 psi operation. Coupled to Waters mass spectrometers, the system delivers the sensitivity to quantify and to identify vanishingly small concentrations of key molecules....

Dates and Agenda Set, Registration Now Open for Quantitative Proteomics and ProteoMMX 3.0 Events

Waters Corporation (NYSE:WAT) and the Biochemical Society announced today the opening of registration for the Biochemical Society’s Quantitative Proteomics Training Day and the ProteoMMX 3.0 Symposium, consecutive events taking place March 24 - 27, 2014 in Chester, England. The Quantitative Proteomics Training Day is aimed at researchers seeking to gain familiarity with the field of quantitative proteomics. ProteoMMX 3.0, following immediately after the Training Day, is dedicated to current thinking and state of the art research in quantitative proteomics...

Waters Introduces the ACQUITY QDa Detector, Bringing Push-Button Mass Detection to Chromatography

Detector Puts the Power of Mass Detection Within Reach of Every Analytical Scientist. Waters Corporation (NYSE:WAT) today introduced the new Waters® ACQUITY  QDa™ Detector, the first mass detector to bring high-quality, mass spectral data to chromatographic separations. Waters is now shipping the new mass detector worldwide. Designed as a synergistic component of a chromatographic system, the ACQUITY QDa Detector is compatible with Waters ACQUITY® UltraPerformance LC® (UPLC®), ACQUITY UltraPerformance Convergence Chromatography™ (UPC2®), Alliance® high performance liquid chromatography (HPLC) and Waters supercritical fluid chromatography (SFC) and LC-based purification systems...

New Process Reduces Waiting Period from Twenty-one Days to Two Days

Environmental Resource Associates (ERA), a Waters^® Business, recently completed a nine-month project to significantly reduce the turnaround time for reporting laboratory proficiency testing (PT) results. Beginning August 1, ERA’s innovative new process will allow customers to know within two business days of a study close if they pass or fail a proficiency test – nineteen days faster than before...

The Oasis Tool Recommends Optimized Protocols Customized to Customer's Samples

Waters Corporation (NYSE: WAT) today unveiled its new web-based Oasis® Method Development Tools designed to help customers reduce their sample preparation method development time as part of Waters Simple Prep™ campaign. Based on the customers’ sample requirements, the Oasis Method Development Tools will recommend the optimized solid-phase extraction (SPE) protocol to develop robust methods with high recovery for liquid chromatography and mass spectrometry applications...

Program will emphasize a combination of training in classical clinical chemistry and specialty areas

Waters Corporation (NYSE:WAT) announced today sponsorship of a new, two-year, postdoctoral Clinical Chemistry Fellowship at the University of California, San Diego School of Medicine. Fellows will be trained in classical clinical chemistry, laboratory administration and research practices to prepare them for directorship positions at medical schools or hospital-based clinical chemistry laboratories. “Our mission is to develop the next generation of leaders in clinical chemistry,” said Robert Fitzgerald, Ph.D., DABCC, UC San Diego School of Medicine professor of pathology and faculty coordinator of the new Clinical Chemistry Fellowship program...

Waters Introduces CORTECS Columns Featuring Solid-Core Particle Technology 

New Family of UltraPerformance LC Columns Pushes the Limits of Separation Efficiency and Throughput. Waters Corporation (NYSE:WAT) today introduced CORTECS™ Columns, a new family of 1.6 micron solid-core UltraPerformance LC® Columns that set a new standard in LC column performance. The higher efficiency brought to chromatography with CORTECS Columns allows laboratories to produce greater amounts of information faster with every chromatographic separation...

Center Recognized by Waters Centers of Innovation Program for Research into Food and Flavor Chemistry

At a ceremony at the University of Minnesota, Waters welcomed the Flavor Research and Education Center within the Food Science and Nutrition Department at the University of Minnesota into its Centers of Innovation Program. The Flavor Research and Education Center under the direction of Prof. Devin Peterson and Prof. Gary Reineccius strives to develop a science-based understanding of food flavor and related chemistry, in particular, flavor generation, characterization of flavor compounds, and flavor delivery in foodstuffs....

At ASMS Waters is previewing an enhanced range of Omics Research Platform Solutions, powered by TransOmics™ 2.0 Informatics. 

Waters Corporation (NYSE:WAT) has unveiled the new Waters® SYNAPT® G2-Si Mass Spectrometer at the 61st conference of the American Society of Mass Spectrometry (ASMS).

The company is also previewing its UNIFI® CCS Research Edition and the new TransOmics Version 2.0 informatics products for the new SYNAPT G2-Si mass spectrometer and demonstrating their benefits for a variety of small molecule applications and cutting-edge Omics-focused research. The SYNAPT G2-Si System integrates a third dimension of resolution and separation power into a new suite of untargeted and targeted LC/MS/MS workflows. This powerful new tool gives researchers a means with which to gain a deeper understanding of molecular biology and disease mechanisms, to develop the next generation of healthcare treatments or chemical materials, or to screen food products or environmental samples for contaminants...

UNIFI 1.6 is Industry’s First Multi-User, Server-Based Technology for Management of Analytical LC, LC/MS, and LC/MS/MS Data

Waters Corporation (NYSE: WAT) is now shipping UNIFI^® Scientific Information System, release version 1.6, for the Waters^® Biopharmaceutical Platform Solution, Regulated Bioanalysis Platform Solution, Screening Platform Solution, Pesticide Screening Application Solution and Metabolite Identification Application Solution. UNIFI 1.6 features improved software performance, default and customizable workflows capabilities, and multi-user server-based connectivity....

Structural Proteomics Laboratory Directed by Prof. Dr. Amit Kumar Mandal Recognized for Global Disease Research

At a ceremony at St. John’s Research Institute (Bangalore, India) Waters announced the selection of the St. John’s Research Institute for its Centers of Innovation Program for research in the field of structural proteomics. It is the first institution in India to receive the designation of a Waters® Center of Innovation. Under the direction of Prof. Dr. Amit Kumar Mandal, a Professor of Molecular Medicine and Clinical Proteomics, St. John’s has earned a reputation for its research in blood disorders and other diseases that disproportionately affect disadvantaged populations...

Based on customer demand Waters Corporation today announced improvements to the Waters Alliance HPLC System. The updated system will maintain key Alliance performance specifications and control algorithms to ensure that analysts can seamlessly replicate their existing methods

Waters Re-Ignites Innovation in the Chemical Materials Market with ACQUITY APC

Waters Empower Software Now Works Seamlessly with DANI Headspace and GC instruments

Waters Corporation (NYSE: WAT) and DANI Instruments today announced that Waters® Empower® Chromatography Data Software now provides control for DANI Headspace and Gas Chromatography instruments. Through this partnership, customers will now be able to take advantage of the full potential of both companies.Empower Software enables laboratory-based organizations to protect their original instrument investment by controlling a vast range of chromatographic modules, connecting them to arguably the most powerful data management system and reporting tool in the industry...

New Charged Surface Hybrid Particles Lead to Greater Loading, Separation Efficiency and Enhanced Information from  UPLC, HPLC and LC-MS Assays

Complementing the Expanded Biopharmaceutical Platform Solution are New Charged Surface Hybrid Particle Column and GlycoWorks Kit for Glycan Preparation

A major new international food safety training facility, aimed at improving compliance with EU food import standards, is being launched today by The Food and Environment Research Agency (Fera) and analytical equipment manufacturer Waters®

A significant proportion of food safety incidents reported in the EU are due to imports, therefore ensuring the legal compliance and safety of imported food is vital for protecting consumers. The EU and other international organisations have recognised the value of improving food safety testing globally, so that risks can be identified and tackled at source. In the EU alone the value of exports and imports of foodstuffs today exceeds £690 billion (over 860 billion Euros)...

The Definitive Handbook Enlightens and Teaches Chemistry Students and Professors, Separations Scientists and Analytical Chemists

Free Catalog Now With Information on Waters Complete Line of Standards and Reagents

Mass Spectrometry Research by Professor David Clemmer Has Paved the Way for New Discoveries in Proteomics and Protein Characterization

Environmental Research at Laboratory Directed by Professor Bert van Bavel Pivotal for Carrying Out Provisions of Stockholm Convention on Persistent Organic Pollutants

Exclusive Agreement With Spark Holland Makes Waters ACQUITY UPLC System Fully Compatible With Spark Holland Symbiosis Online Solid Phase Extraction Technology

New Laboratory Directed by Prof. Vladimir Shulaev Recognized for Metabolomics and Metabolic Signaling Pathway Research and Teaching